CT detected indeterminate pulmonary nodules in a chemoprevention trial of fluticasone

Lung Cancer

Volumn 60, Issue 1, 2008, Pages 57-61

  van den Berg, Remco M ^a   Teertstra, H Jelle ^b   van Zandwijk, Nico ^b   van Tinteren, Harm ^b   Visser, Christien ^b   Pasic, Arifa ^a   Sutedja, Thomas G ^a   Baas, Paul ^b   Golding, Richard P ^a   Postmus, Pieter E ^a   Smit, Egbert F ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

Chemoprevention; Computer tomography; Inhaled corticosteroids; Lung cancer; Pulmonary nodules; Trial

Indexed keywords

FLUTICASONE; PLACEBO;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INHIBITION; CHEMOPROPHYLAXIS; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; FEMALE; HUMAN; LUNG CANCER; LUNG NODULE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SQUAMOUS CELL METAPLASIA; THORAX RADIOGRAPHY; TREATMENT DURATION;

ADULT; AGED; ANDROSTADIENES; COIN LESION, PULMONARY; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 41149177676     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2007.09.007     Document Type: Article

References (23)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 55 2 (2005) 74-108
2. Hecht S.S. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 91 14 (1999) 1194-1210
3. Tong L., Spitz M.R., Fueger J.J., and Amos C.A. Lung carcinoma in former smokers. Cancer 78 5 (1996) 1004-1010
4. Thun M.J., Lally C.A., Flannery J.T., Calle E.E., Flanders W.D., and Heath Jr. C.W. Cigarette smoking and changes in the histopathology of lung cancer. J Natl Cancer Inst 89 21 (1997) 1580-1586
5. Wang Y., Zhang Z., Kastens E., Lubet R.A., and You M. Mice with alterations in both p53 and Ink4a/Arf display a striking increase in lung tumor multiplicity and progression: differential chemopreventive effect of budesonide in wild-type and mutant A/J mice. Cancer Res 63 15 (2003) 4389-4395
6. Wattenberg L.W., Wiedmann T.S., Estensen R.D., Zimmerman C.L., Galbraith A.R., Steele V.E., et al. Chemoprevention of pulmonary carcinogenesis by brief exposures to aerosolized budesonide or beclomethasone dipropionate and by the combination of aerosolized budesonide and dietary myo-inositol. Carcinogenesis 21 2 (2000) 179-182
7. Greenberg A.K., Hu J., Basu S., Hay J., Reibman J., Yie T., et al. Glucocorticoids inhibit lung cancer cell growth through both the extracellular signal-related kinase pathway and cell cycle regulators. Am J Respir Cell Mol Biol 27 3 (2002) 320-328
8. Parimon T., Chien J.W., Bryson C.L., McDonell M.B., Udris E.M., and Au D.H. Inhaled corticosteroids and risk of lung cancer among patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 175 7 (2007) 712-719
9. Lam S., leRiche J.C., McWilliams A., Macaulay C., Dyachkova Y., Szabo E., et al. A randomized phase IIb trial of pulmicort turbuhaler (budesonide) in people with dysplasia of the bronchial epithelium. Clin Cancer Res 10 19 (2004) 6502-6511
10. Van Den Berg R.M., Van Tinteren H., Van Zandwijk N., Visser C., Pasic A., Kooi C., et al. The influence of fluticasone inhalation on markers of carcinogenesis in bronchial epithelium. Am J Respir Crit Care Med 175 10 (2007) 1061-1065
11. Altman D.G., and Bland J.M. Statistics notes: units of analysis. BMJ 314 7098 (1997) 1874
12. Fischbach F., Knollmann F., Griesshaber V., Freund T., Akkol E., and Felix R. Detection of pulmonary nodules by multislice computed tomography: improved detection rate with reduced slice thickness. Eur Radiol V13 10 (2003) 2378-2383
13. Kim J.S., Kim J.H., Cho G., and Bae K.T. Automated detection of pulmonary nodules on CT images: effect of section thickness and reconstruction interval-initial results. Radiology 236 1 (2005) 295-299
14. Miller R.R. Bronchioloalveolar cell adenomas. Am J Surg Pathol 14 10 (1990) 904-912
15. Chapman A.D., and Kerr K.M. The association between atypical adenomatous hyperplasia and primary lung cancer. Br J Cancer 83 5 (2000) 632-636
16. Logan P.M., Miller R.R., Evans K., and Muller N.L. Bronchogenic carcinoma and coexistent bronchioloalveolar cell adenomas. Assessment of radiologic detection and follow-up in 28 patients. Chest 109 3 (1996) 713-717
17. Ishikawa H., Koizumi N., Morita T., Tani Y., Tsuchida M., Umezu H., et al. Ultrasmall pulmonary opacities on multidetector-row high-resolution computed tomography: a prospective radiologic-pathologic examination. J Comput Assist Tomogr 29 5 (2005) 621-625
18. Yuan Y., Matsumoto T., Hiyama A., Miura G., Tanaka N., Emoto T., et al. The probability of malignancy in small pulmonary nodules coexisting with potentially operable lung cancer detected by CT. Eur Radiol 13 11 (2003) 2447-2453
19. Yokose T., Doi M., Tanno K., Yamazaki K., and Ochiai A. Atypical adenomatous hyperplasia of the lung in autopsy cases. Lung Cancer 33 2/3 (2001) 155-161
20. Yokose T., Ito Y., and Ochiai A. High prevalence of atypical adenomatous hyperplasia of the lung in autopsy specimens from elderly patients with malignant neoplasms. Lung Cancer 29 2 (2000) 125-130
21. Ohtsuka T., Watanabe Ki, Kaji M., Naruke T., and Suemasu K. A clinicopathological study of resected pulmonary nodules with focal pure ground-glass opacity. Eur J Cardiothorac Surg 30 1 (2006) 160-163
22. Ohta Y., Shimizu Y., Kobayashi T., Matsui O., Minato H., Matsumoto I., et al. Pathologic and biological assessment of lung tumors showing ground-glass opacity. Ann Thorac Surg 81 4 (2006) 1194-1197
23. Li F., Sone S., Abe H., MacMahon H., and Doi K. Malignant versus benign nodules at CT screening for lung cancer: comparison of thin-section CT findings. Radiology 233 3 (2004) 793-798